Stockreport

NeOnc Technologies Reports Updated Clinical Results

NeOnc Technologies Holdings, Inc.  (NTHI) 
PDF CALABASAS, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) -- NeOnc Technologies Holdings, Inc. (NTHI) (“NeOnc” or the “Company”), a multi–Phase 2 clinical-stage biopharmaceut [Read more]